The cold and cough preparations market reached a value of nearly $66,754.2 million in 2022, having grown at a compound annual growth rate (CAGR) of 8.6% since 2017. The market is expected to grow from $66,754.2 million in 2022 to $84,021.9 million in 2027 at a rate of 4.7%. The market is then expected to grow at a CAGR of 4.2% from 2027 and reach $103,384.5 million in 2032.
Growth in the historic period resulted from increased prevalence of respiratory diseases, increased incidence of tobacco smoking, global warming, strong economic growth in emerging markets and rise in healthcare expenditure. Factors that negatively affected growth in the historic period were expiration of patents and political uncertainties.
Going forward, increased popularity of e-cigarettes/ vaping, rising obesity levels, large pool of undiagnosed population and government initiatives will drive the growth. Factors that could hinder the growth of the cold and cough preparations market in the future include side effects associated with respiratory drugs, reduction in free trade and Russia-Ukraine war impact.
The cold and cough preparations market is segmented by drug type into antihistamines, expectorants, bronchodilators, decongestants, antibiotics, other drug types. The bronchodilators market was the largest segment of the cold and cough preparations market segmented by drug type, accounting for 30.1% of the total in 2022. Going forward, the expectorants segment is expected to be the fastest growing segment in the cold and cough preparations market segmented by drug type, at a CAGR of 5.1% during 2022-2027.
The cold and cough preparations market is segmented by dosage type into oral syrups, tablets/pills, nasal drops, lozenges and other dosage types. The tablets/pills market was the largest segment of the cold and cough preparations market segmented by dosage type, accounting for 45.0% of the total in 2022. Going forward, the tablets/pills segment is expected to be the fastest growing segment in the cold and cough preparations market segmented by dosage type, at a CAGR of 5.1% during 2022-2027.
The cold and cough preparations market is segmented by distribution channel into hospital pharmacies, retail pharmacies and drug stores and other distribution channels. The retail pharmacies and drug stores market was the largest segment of the cold and cough preparations market segmented by distribution channel, accounting for 57.4% of the total in 2022. Going forward, the other distribution channels segment is expected to be the fastest growing segment in the cold and cough preparations market segmented by distribution channel, at a CAGR of 4.9% during 2022-2027.
North America was the largest region in the cold and cough preparations market, accounting for 38.8% of the total in 2022. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the cold and cough preparations market will be Asia Pacific and North America where growth will be at CAGRs of 5.3% and 4.8% respectively. These will be followed by Western Europe and Eastern Europe where the markets are expected to grow at CAGRs of 4.4% and 3.9% respectively.
The Global cough and cold preparations market is fragmented, with a large number of small players. The top ten competitors in the market made up to 11.15% of the total market in 2021. Technological innovations in the recent past helped the companies to strengthen their market presence. Johnson & Johnson was the largest competitor with 2.29% share of the market, followed by GlaxoSmithKline plc with 2.08%, Procter & Gamble with 1.75%, Bayer AG with 1.62%, Reckitt Benckiser Group plc with 1.33%, Novartis AG with 1.09%, Perrigo Company with 0.46%, Sun Pharmaceutical Industries Ltd. with 0.28%, Prestige Consumer Healthcare with 0.17%, and Blackmores Limited with 0.08%.
The top opportunities in the cold and cough preparations market segmented by drug type will arise in the bronchodilators segment, which will gain $5,223.0 million of global annual sales by 2027. The top opportunities in the cold and cough preparations market segmented by dosage type will arise in the tablets/pills segment, which will gain $8,435.9 million of global annual sales by 2027. The top opportunities in the cold and cough preparations market segmented by distribution channel will arise in the retail pharmacies and drug stores segment, which will gain $10,153.7 million of global annual sales by 2027. The cold and cough preparations market size will gain the most in USA at $6,810.2 million.
Market-trend-based strategies for the cold and cough preparations market include use of probiotics to treat asthma, advanced bronchodilators launched, new product launches, mergers and collaborations in the market, increasing demand for personalized medicines, demand for aerosol respiratory drugs, rise of generic respiratory drugs and combination drug therapy to treat COPD.
Player-adopted strategies in the cold and cough preparations market includes focus on expanding operational capabilities through strategic acquisitions, enhancing business operations and product portfolio through the launch of new products.
To take advantage of the opportunities, the publisher recommends the cold and cough preparations companies to focus on new product launches, focus on personalized medicines, focus on combination drug therapy to treat COPD, continue to focus on developed markets, focus on strategic collaborations and acquisitions, focus on competitive pricing, participate in medicine seminars and conferences and target hospitals and pharmacies to spread awareness.
This report describes and explains the cough and cold preparations market and covers 2017 to 2022, termed the historic period, and 2022 to 2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.
Growth in the historic period resulted from increased prevalence of respiratory diseases, increased incidence of tobacco smoking, global warming, strong economic growth in emerging markets and rise in healthcare expenditure. Factors that negatively affected growth in the historic period were expiration of patents and political uncertainties.
Going forward, increased popularity of e-cigarettes/ vaping, rising obesity levels, large pool of undiagnosed population and government initiatives will drive the growth. Factors that could hinder the growth of the cold and cough preparations market in the future include side effects associated with respiratory drugs, reduction in free trade and Russia-Ukraine war impact.
The cold and cough preparations market is segmented by drug type into antihistamines, expectorants, bronchodilators, decongestants, antibiotics, other drug types. The bronchodilators market was the largest segment of the cold and cough preparations market segmented by drug type, accounting for 30.1% of the total in 2022. Going forward, the expectorants segment is expected to be the fastest growing segment in the cold and cough preparations market segmented by drug type, at a CAGR of 5.1% during 2022-2027.
The cold and cough preparations market is segmented by dosage type into oral syrups, tablets/pills, nasal drops, lozenges and other dosage types. The tablets/pills market was the largest segment of the cold and cough preparations market segmented by dosage type, accounting for 45.0% of the total in 2022. Going forward, the tablets/pills segment is expected to be the fastest growing segment in the cold and cough preparations market segmented by dosage type, at a CAGR of 5.1% during 2022-2027.
The cold and cough preparations market is segmented by distribution channel into hospital pharmacies, retail pharmacies and drug stores and other distribution channels. The retail pharmacies and drug stores market was the largest segment of the cold and cough preparations market segmented by distribution channel, accounting for 57.4% of the total in 2022. Going forward, the other distribution channels segment is expected to be the fastest growing segment in the cold and cough preparations market segmented by distribution channel, at a CAGR of 4.9% during 2022-2027.
North America was the largest region in the cold and cough preparations market, accounting for 38.8% of the total in 2022. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the cold and cough preparations market will be Asia Pacific and North America where growth will be at CAGRs of 5.3% and 4.8% respectively. These will be followed by Western Europe and Eastern Europe where the markets are expected to grow at CAGRs of 4.4% and 3.9% respectively.
The Global cough and cold preparations market is fragmented, with a large number of small players. The top ten competitors in the market made up to 11.15% of the total market in 2021. Technological innovations in the recent past helped the companies to strengthen their market presence. Johnson & Johnson was the largest competitor with 2.29% share of the market, followed by GlaxoSmithKline plc with 2.08%, Procter & Gamble with 1.75%, Bayer AG with 1.62%, Reckitt Benckiser Group plc with 1.33%, Novartis AG with 1.09%, Perrigo Company with 0.46%, Sun Pharmaceutical Industries Ltd. with 0.28%, Prestige Consumer Healthcare with 0.17%, and Blackmores Limited with 0.08%.
The top opportunities in the cold and cough preparations market segmented by drug type will arise in the bronchodilators segment, which will gain $5,223.0 million of global annual sales by 2027. The top opportunities in the cold and cough preparations market segmented by dosage type will arise in the tablets/pills segment, which will gain $8,435.9 million of global annual sales by 2027. The top opportunities in the cold and cough preparations market segmented by distribution channel will arise in the retail pharmacies and drug stores segment, which will gain $10,153.7 million of global annual sales by 2027. The cold and cough preparations market size will gain the most in USA at $6,810.2 million.
Market-trend-based strategies for the cold and cough preparations market include use of probiotics to treat asthma, advanced bronchodilators launched, new product launches, mergers and collaborations in the market, increasing demand for personalized medicines, demand for aerosol respiratory drugs, rise of generic respiratory drugs and combination drug therapy to treat COPD.
Player-adopted strategies in the cold and cough preparations market includes focus on expanding operational capabilities through strategic acquisitions, enhancing business operations and product portfolio through the launch of new products.
To take advantage of the opportunities, the publisher recommends the cold and cough preparations companies to focus on new product launches, focus on personalized medicines, focus on combination drug therapy to treat COPD, continue to focus on developed markets, focus on strategic collaborations and acquisitions, focus on competitive pricing, participate in medicine seminars and conferences and target hospitals and pharmacies to spread awareness.
This report describes and explains the cough and cold preparations market and covers 2017 to 2022, termed the historic period, and 2022 to 2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.
Table of Contents
1. Executive Summary2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Cough And Cold Preparations Market Definition and Segmentations
6.4. Market Segmentation by Drug Type
6.4.1. Antihistamines
6.4.2. Expectorants
6.4.3. Bronchodilators
6.4.4. Decongestants
6.4.5. Antibiotics
6.4.6. Other Drug Type
6.5. Market Segmentation by Dosage Type
6.5.1. Oral Syrups
6.5.2. Tablets/Pills
6.5.3. Nasal Drops
6.5.4. Lozenges
6.5.5. Other Dosage Types
6.6. Market Segmentation by Distribution Channel
6.6.1. Hospital Pharmacies
6.6.2. Retail Pharmacies And Drug Stores
6.6.3. Other Distribution Channels
7. Major Market Trends
7.1. Use Of Probiotics To Treat Asthma
7.2. Advanced Bronchodilators Launched
7.3. New Product Launches
7.4. Mergers And Collaborations In The Market
7.5. Increasing Demand For Personalized Medicines
7.6. Demand For Aerosol Respiratory Drugs
7.7. Rise Of Generic Respiratory Drugs
7.8. Combination Drug Therapy To Treat COPD
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 - 2022, Value ($ Million)
8.2.1. Market Drivers 2017 - 2022
8.2.2. Market Restraints 2017 - 2022
8.3. Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 - 2027
8.3.2. Market Restraints 2022 - 2027
9. Global Cough And Cold Preparations Market Segmentation
9.1. Global Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
10. Cough And Cold Preparations Market, Regional and Country Analysis
10.1. Global Cough And Cold Preparations Market, By Region, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Cough And Cold Preparations Market, By Country, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.4. Asia-Pacific Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Cough And Cold Preparations Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Major Associations
11.11.7. Taxes levied
11.11.8. Corporate tax structure
11.11.9. Investments
11.11.10. Major Companies
11.12. China Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.13. China Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.14. China Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.15. China Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.16. China Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.19. India Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.20. India Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.21. India Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.22. India Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.25. Japan Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.26. Japan Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.31. Australia Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.32. Australia Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.37. Indonesia Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.38. Indonesia Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.43. South Korea Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.44. South Korea Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes levied
12.2.9. Corporate tax structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.4. Western Europe Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.5. Western Europe Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Cough And Cold Preparations Market: Country Analysis
12.9. UK Market
12.10. UK Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.11. UK Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.12. UK Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.17. Germany Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.18. Germany Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.23. France Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.24. France Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.25. France Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.26. France Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
13.4. Eastern Europe Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
13.5. Eastern Europe Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Cough And Cold Preparations Market: Country Analysis
13.9. Russia Market
13.10. Russia Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
13.11. Russia Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
13.12. Russia Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
14.4. North America Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
14.5. North America Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Cough And Cold Preparations Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Region Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Government Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
14.13. USA Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
14.14. USA Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
15.4. South America Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
15.5. South America Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Cough And Cold Preparations Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
15.11. Brazil Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
15.12. Brazil Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
16.4. Middle East Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
16.5. Middle East Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Cough And Cold Preparations Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
17.4. Africa Cough And Cold Preparations Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
17.5. Africa Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape And Company Profiles
18.1. Company Profiles
18.2. Johnson & Johnson
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. GlaxoSmithKline plc
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. The Procter & Gamble Company
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Business Strategy
18.4.4. Financial Overview
18.5. Bayer AG
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Financial Overview
18.6. Reckitt Benckiser Group plc
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Financial Overview
19. Key Mergers and Acquisitions
19.1. Olympus Corporation Acquired Veran Medical Technologies, Inc. (VMT)
19.2. Mankind Pharma Acquired Dr. Reddy's
19.3. Sandoz International GmbH Acquired Coalesce Product Development
19.4. Pfizer Acquired ReViral
19.5. AstraZeneca Gets US Clearance For Proposed Alexion Acquisition
19.6. ResMed Acquired Propeller Health
20. Opportunities And Strategies
20.1. Global Cough And Cold Preparations Market In 2027 - Countries Offering Most New Opportunities
20.2. Global Cough And Cold Preparations Market In 2027 - Segments Offering Most New Opportunities
20.3. Global Cough And Cold Preparations Market In 2027 - Growth Strategies
20.3.1. Market Trend Based Strategies
20.3.2. Competitor Strategies
21. Cough And Cold Preparations Market, Conclusions And Recommendations
21.1. Conclusions
21.2. Recommendations
21.2.1. Product
21.2.2. Place
21.2.3. Price
21.2.4. Promotion
21.2.5. People
22. Appendix
22.1. Market Data Sources
22.2. Research Methodology
22.3. Currencies
22.4. About the Publisher
22.5. Copyright and Disclaimer
Executive Summary
Cough And Cold Preparations Global Market Opportunities And Strategies To 2032 provides the strategists; marketers and senior management with the critical information they need to assess the global cough and cold preparations market as it emerges from the COVID 19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider cough and cold preparations market; and compares it with other markets.
The report covers the following chapters:
- Introduction and Market Characteristics
- Key Trends
- Global Market Size and Growth
- Regional Analysis
- Market Segmentation
- Regional Market Size and Growth
- Competitive Landscape
- Key Mergers and Acquisitions
- Market Opportunities And Strategies
- Conclusions And Recommendations
- Appendix
Scope
Markets Covered
1) By Drug Type: Antihistamines; Expectorants; Bronchodilators; Decongestants; Antibiotics; Other Drug Types.2) By Dosage Type: Oral Syrups; Tablets/Pills; Nasal Drops; Lozenges; Other Dosage Types
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores; Other Distribution Channels.
Companies Mentioned: Johnson & Johnson; GlaxoSmithKline plc; Procter & Gamble; Bayer AG; Reckitt Benckiser Group plc
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; cough and cold preparations indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Johnson & Johnson
- GlaxoSmithKline plc
- Procter & Gamble
- Bayer AG
- Reckitt Benckiser Group plc
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 317 |
| Published | February 2023 |
| Forecast Period | 2022 - 2032 |
| Estimated Market Value ( USD | $ 66754.2 Million |
| Forecasted Market Value ( USD | $ 103384.5 Million |
| Compound Annual Growth Rate | 4.5% |
| Regions Covered | Global |
